Ultragenyx Pharmaceutical Inc.
RARE • Healthcare
About Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally.
Quality Assessment
Ultragenyx Pharmaceutical Inc. is a high-risk healthcare company with a Compass Score of 7. This stock has poor quality metrics and high risk. Not recommended for conservative investors.
Score Breakdown
The Compass Score is based on 6 quality factors identified by academic research.
Click any factor to see detailed metrics
Valuation Metrics
Click any metric for details
Technical Overview
Click any metric for details
Wall Street View
Growth Projections
Financial Health
Click any metric for details
Similar High-Quality Stocks
MCRB
Seres Therapeutics, Inc.
ADPT
Adaptive Biotechnologies Corporation
HRTX
Heron Therapeutics, Inc.
JANX
Janux Therapeutics, Inc.
STRR
Star Equity Holdings, Inc.
ORMP
Oramed Pharmaceuticals Inc.
Important Disclaimer
The Compass Score is for educational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consider consulting a financial advisor before making investment decisions.
Unlock Detailed Metrics
Upgrade to Basic to see the actual financial values behind each quality factor.
- See exact ROA, cash flow ratios, and more
- Unlimited stock lookups
- Export data to CSV
- 7-day free trial included
Cancel anytime